New hope for kids with deadly brain tumors: experimental therapy targets cancer directly in the brain
NCT ID NCT05768880
Summary
This early-stage study is testing a new type of personalized immune cell therapy called SC-CAR4BRAIN for children and young adults with aggressive brain tumors that have come back or not responded to standard treatments. Doctors collect a patient's own immune cells, modify them in a lab to better recognize and attack four specific targets on the tumor, and then deliver these 'supercharged' cells directly into the fluid-filled spaces of the brain through a special catheter. The main goals are to see if this complex treatment can be made safely, determine the best dose, and check if it's feasible to give to patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY PRIMARY MALIGNANT CENTRAL NERVOUS SYSTEM NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seattle Children's Hospital
Seattle, Washington, 98105, United States
Conditions
Explore the condition pages connected to this study.